TASLANZ Trademark

Trademark Overview

On Friday, March 28, 2014, a trademark application was filed for TASLANZ with the United States Patent and Trademark Office. The USPTO has given the TASLANZ trademark a serial number of 86235866. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 4, 2017. This trademark is owned by Relypsa, Inc.. The TASLANZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of hyperkalemia; pharmaceutical preparations for the treatment and prevention of renal, cardiovascular, gastrointestinal and endocrine diseases or disorders; pharmaceutical preparations for reducing potassium levels; non-absorbed pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of hyperkalemia and renal, cardiovascular, gastrointestinal, and endocrine disorders; polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of hyperkalemia and renal, cardiovascular, gastrointestinal, and endocrine disorders
taslanz

General Information

Serial Number86235866
Word MarkTASLANZ
Filing DateFriday, March 28, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 4, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 2, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of hyperkalemia; pharmaceutical preparations for the treatment and prevention of renal, cardiovascular, gastrointestinal and endocrine diseases or disorders; pharmaceutical preparations for reducing potassium levels; non-absorbed pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of hyperkalemia and renal, cardiovascular, gastrointestinal, and endocrine disorders; polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of hyperkalemia and renal, cardiovascular, gastrointestinal, and endocrine disorders
Translation of Words in MarkThe wording "Taslanz" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 11, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRelypsa, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063
Party NameRelypsa, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Trademark Events

Event DateEvent Description
Monday, December 4, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 4, 2017ABANDONMENT - NO USE STATEMENT FILED
Saturday, May 6, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 5, 2017EXTENSION 5 GRANTED
Thursday, April 27, 2017EXTENSION 5 FILED
Thursday, April 27, 2017TEAS EXTENSION RECEIVED
Tuesday, November 1, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 28, 2016EXTENSION 4 GRANTED
Friday, October 28, 2016EXTENSION 4 FILED
Friday, October 28, 2016TEAS EXTENSION RECEIVED
Saturday, April 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 28, 2016EXTENSION 3 GRANTED
Thursday, April 28, 2016EXTENSION 3 FILED
Thursday, April 28, 2016TEAS EXTENSION RECEIVED
Saturday, November 7, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 6, 2015EXTENSION 2 GRANTED
Wednesday, October 28, 2015EXTENSION 2 FILED
Thursday, November 5, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 28, 2015TEAS EXTENSION RECEIVED
Thursday, June 18, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 18, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 28, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 24, 2015EXTENSION 1 GRANTED
Friday, April 24, 2015EXTENSION 1 FILED
Friday, April 24, 2015TEAS EXTENSION RECEIVED
Tuesday, October 28, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 2, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 2, 2014PUBLISHED FOR OPPOSITION
Wednesday, August 13, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 31, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, July 31, 2014ASSIGNED TO LIE
Monday, July 21, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 1, 2014EXAMINER'S AMENDMENT ENTERED
Tuesday, July 1, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 1, 2014EXAMINERS AMENDMENT E-MAILED
Tuesday, July 1, 2014EXAMINERS AMENDMENT -WRITTEN
Monday, June 30, 2014ASSIGNED TO EXAMINER
Friday, April 11, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 1, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

taslanz pharmaceutical preparations prevention treatment gastrointestinal disorders endocrine hyperkalemia renal cardiovascular